MedTrace Logo

Evaluation of Posterior Capsule Opacification in Eyes With Diabetes Mellitus

NCT01480934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2011-11-29

No results posted yet for this study

Summary

To compare the development of posterior capsule opacification (PCO) between eyes with and without a history of diabetes mellitus (DM) after single-piece hydrophobic acrylic intraocular lens (IOL) implantation 4 years postoperatively.Diabetes mellitus would not increase the incidence of PCO at 4 years.

Conditions

  • Development of Posterior Capsule Opacification

Sponsors & Collaborators

  • Iladevi Cataract and IOL Research Center

    lead OTHER

Principal Investigators

  • Gauri D Shah, M.S · Iladevi Cataract &IOL Research Centre

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2010-01-31
Completion
2010-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01480934 on ClinicalTrials.gov